Jason Zook, MD
Orthopaedic Surgery · Morganton, NCNPI 1114131786
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (45.9%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Globus Medical accounts for 64.5% of it on its own, with 59 other manufacturers making up the rest. Among orthopaedic surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 896 payments — averaging $881.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$509K
- Medacta USA, Inc.$85K
- Intrinsic Therapeutics$51K
- Cutting Edge Spine, LLC$49K
- Choice Spine, LLC$24K
- Integrity Implants Inc.$21K
- plus $50K from 54 others
Across 3 payments — averaging $5216.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intrinsic Therapeutics$16K
What the payments were for
- Royalty or licence$362,07246%
- Consulting fees$163,12421%
- Speaking & faculty fees$151,00319%
- Travel & lodging$87,24211%
- Food & beverage$24,9863%
- Education$3490%
- Gifts$440%
- Charitable contribution$6170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CREO$175,606
- Excelsius - GPS$109,583
- BARRICAID ACD (ANNULAR CLOSURE DEVICE)$98,084
- CREO ONE Robotic Screw$87,719
- MYSPINE$64,166
- CREO Threaded$48,650
- LineSider$17,867
- MUST$16,250
- Posterior Occipito-Cervico-Thoracic Project$12,429
- PRONE LATERAL$11,357
- Boomerang$11,040
- Next Gen Lateral$10,313
- EXCELSIUS$8,444
- ELSA$7,959
- CREO MCS$7,601
- Nexxt Matrixx SI Helixx$7,120
- Nexxt Matrixx SI Instrumentation$7,120
- FlareHawk$6,972
- MIS Self Drilling Screw$6,905
- Tomcat Ti$6,885
How this compares
$789,438 in reported general payments places this provider in the 95th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 58 | $678 |
| Mupirocin | 88 | $578 |
| Methylprednisolone | 95 | $543 |
| Celecoxib | 56 | $513 |
| Gabapentin | 34 | $192 |
| Methocarbamol | 35 | $162 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $159 |
| Tizanidine Hcl | 25 | $156 |
| Meloxicam | 25 | $59 |
| Diazepam | 15 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Morganton
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$5.7M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$4.9M
- Mark EasleyDurham$4M
- Carroll JonesCharlotte$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.